{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:09:27Z","timestamp":1785179367830,"version":"3.55.0"},"reference-count":61,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"DOI":"10.1167\/tvst.8.6.2","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T15:30:46Z","timestamp":1572622246000},"page":"2","source":"Crossref","is-referenced-by-count":94,"title":["Physicochemical Properties of Hyaluronic Acid\u2013Based Lubricant Eye Drops"],"prefix":"10.1167","volume":"8","author":[{"given":"Pasquale","family":"Aragona","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, Regional Referral Center for Ocular Surface Diseases, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Simmons","sequence":"additional","affiliation":[{"name":"Allergan plc, Irvine, CA, USA"},{"name":"School of Optometry and Vision Science, Faculty of Science, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Allergan plc, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Allergan plc, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"i2164-2591-8-6-2-b01","doi-asserted-by":"crossref","unstructured":"Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother. 2011; 12: 325\u2013334.","DOI":"10.1517\/14656566.2010.518612"},{"key":"i2164-2591-8-6-2-b02","doi-asserted-by":"crossref","unstructured":"Paugh JR, Nguyen AL, Ketelson HA, Christensen MT, Meadows DL. Precorneal residence time of artificial tears measured in dry eye subjects. Optom Vis Sci. 2008; 85: 725\u2013731.","DOI":"10.1097\/OPX.0b013e3181824de3"},{"key":"i2164-2591-8-6-2-b03","doi-asserted-by":"crossref","unstructured":"Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013; 9: 7081\u20137092.","DOI":"10.1016\/j.actbio.2013.03.005"},{"key":"i2164-2591-8-6-2-b04","doi-asserted-by":"crossref","unstructured":"Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. Biorheology. 1994; 31: 339\u2013351.","DOI":"10.3233\/BIR-1994-31404"},{"key":"i2164-2591-8-6-2-b05","doi-asserted-by":"crossref","unstructured":"Weigel PH. Planning, evaluating, and vetting receptor signaling studies to assess hyaluronan size-dependence and specificity. Glycobiology. 2017; 27: 796\u2013799.","DOI":"10.1093\/glycob\/cwx056"},{"key":"i2164-2591-8-6-2-b06","doi-asserted-by":"crossref","unstructured":"Cyphert JM, Trempus CS, Garantziotis S. Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol. 2015; 2015: 563818.","DOI":"10.1155\/2015\/563818"},{"key":"i2164-2591-8-6-2-b07","doi-asserted-by":"crossref","unstructured":"Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol. 1993; 122: 257\u2013264.","DOI":"10.1083\/jcb.122.1.257"},{"key":"i2164-2591-8-6-2-b08","doi-asserted-by":"crossref","unstructured":"Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol. 1994; 124: 71\u201382.","DOI":"10.1083\/jcb.124.1.71"},{"key":"i2164-2591-8-6-2-b09","doi-asserted-by":"crossref","unstructured":"Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol. 2005; 243: 531\u2013538.","DOI":"10.1007\/s00417-004-1040-6"},{"key":"i2164-2591-8-6-2-b10","doi-asserted-by":"crossref","unstructured":"Lerner LE, Schwartz DM, Hwang DG, Howes EL, Stern R. Hyaluronan and CD44 in the human cornea and limbal conjunctiva. Exp Eye Res. 1998; 67: 481\u2013484.","DOI":"10.1006\/exer.1998.0567"},{"key":"i2164-2591-8-6-2-b11","doi-asserted-by":"crossref","unstructured":"Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol. 2002; 86: 181\u2013184.","DOI":"10.1136\/bjo.86.2.181"},{"key":"i2164-2591-8-6-2-b12","doi-asserted-by":"crossref","unstructured":"Aragona P, Micali A, Paladino G, Ferreri F, Puzzolo D. Effects of tear substitutes on conjunctival epithelium of mice. Ophthalmic Res. 2007; 39: 265\u2013275.","DOI":"10.1159\/000108120"},{"key":"i2164-2591-8-6-2-b13","doi-asserted-by":"crossref","unstructured":"Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004; 88: 821\u2013825.","DOI":"10.1136\/bjo.2003.027573"},{"key":"i2164-2591-8-6-2-b14","doi-asserted-by":"crossref","unstructured":"Kato T, Nakayasu K, Ikegami K, Obara T, Kanayama T, Kanai A. Analysis of glycosaminoglycans in rabbit cornea after excimer laser keratectomy. Br J Ophthalmol. 1999; 83: 609\u2013612.","DOI":"10.1136\/bjo.83.5.609"},{"key":"i2164-2591-8-6-2-b15","doi-asserted-by":"crossref","unstructured":"Miyauchi S, Sugiyama T, Machida A, et al. The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. I. An in vitro study. J Ocul Pharmacol. 1990; 6: 91\u201399.","DOI":"10.1089\/jop.1990.6.91"},{"key":"i2164-2591-8-6-2-b16","doi-asserted-by":"crossref","unstructured":"Nishida T, Nakamura M, Mishima H, Otori T. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res. 1991; 53: 753\u2013758.","DOI":"10.1016\/0014-4835(91)90110-Z"},{"key":"i2164-2591-8-6-2-b17","doi-asserted-by":"crossref","unstructured":"Yokoi N, Komuro A, Nishida K, Kinoshita S. Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol. 1997; 81: 533\u2013536.","DOI":"10.1136\/bjo.81.7.533"},{"key":"i2164-2591-8-6-2-b18","unstructured":"OmniVision SA. Fermavisc sine. 2006; Available at: https:\/\/www.omnivision.ch\/produkte\/benetzungsmittel\/. Accessed August 15, 2019."},{"key":"i2164-2591-8-6-2-b19","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Amako H, Yamamoto T, Tazawa M, Sakamoto Y. Corneal-protective effects of an artificial tear containing sodium hyaluronate and castor oil on a porcine short-term dry eye model. J Vet Med Sci. 2014; 76: 1219\u20131224.","DOI":"10.1292\/jvms.14-0143"},{"key":"i2164-2591-8-6-2-b20","doi-asserted-by":"crossref","unstructured":"Guillaumie F, Furrer P, Felt-Baeyens O, et al. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications. J Biomed Mater Res A. 2010; 92: 1421\u20131430.","DOI":"10.1002\/jbm.a.32481"},{"key":"i2164-2591-8-6-2-b21","doi-asserted-by":"crossref","unstructured":"White CJ, Thomas CR, Byrne ME. Bringing comfort to the masses: a novel evaluation of comfort agent solution properties. Cont Lens Anterior Eye. 2014; 37: 81\u201391.","DOI":"10.1016\/j.clae.2013.07.004"},{"key":"i2164-2591-8-6-2-b22","doi-asserted-by":"crossref","unstructured":"Labetoulle M, Chiambaretta F, Shirlaw A, Leaback R, Baudouin C. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. Eye. 2017; 31: 1409\u20131416.","DOI":"10.1038\/eye.2017.73"},{"key":"i2164-2591-8-6-2-b23","doi-asserted-by":"crossref","unstructured":"Adam N, Ghosh P. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm Res. 2001; 50: 294\u2013299.","DOI":"10.1007\/PL00000247"},{"key":"i2164-2591-8-6-2-b24","doi-asserted-by":"crossref","unstructured":"Armand G, Reyes M. A new chromatographic method for the fractionation of hyaluronic acid. Biochem Biophys Res Commun. 1983; 112: 168\u2013175.","DOI":"10.1016\/0006-291X(83)91812-0"},{"key":"i2164-2591-8-6-2-b25","doi-asserted-by":"crossref","unstructured":"Hong M, Sudor J, Stefansson M, Novotny MV. High-resolution studies of hyaluronic acid mixtures through capillary gel electrophoresis. Anal Chem. 1998; 70: 568\u2013573.","DOI":"10.1021\/ac970768a"},{"key":"i2164-2591-8-6-2-b26","doi-asserted-by":"crossref","unstructured":"Laurent UB, Granath KA. The molecular weight of hyaluronate in the aqueous humour and vitreous body of rabbit and cattle eyes. Exp Eye Res. 1983; 36: 481\u2013492.","DOI":"10.1016\/0014-4835(83)90042-8"},{"key":"i2164-2591-8-6-2-b27","doi-asserted-by":"crossref","unstructured":"Wright P, Cooper M, Gilvarry AM. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond. Br J Ophthalmol. 1987; 71: 161\u2013164.","DOI":"10.1136\/bjo.71.2.161"},{"key":"i2164-2591-8-6-2-b28","doi-asserted-by":"crossref","unstructured":"Papa V, Aragona P, Russo S, Di Bella A, Russo P, Milazzo G. Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients. Ophthalmologica. 2001; 215: 124\u2013127.","DOI":"10.1159\/000050842"},{"key":"i2164-2591-8-6-2-b29","doi-asserted-by":"crossref","unstructured":"Troiano P, Monaco G. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study. Cornea. 2008; 27: 1126\u20131130.","DOI":"10.1097\/ICO.0b013e318180e55c"},{"key":"i2164-2591-8-6-2-b30","doi-asserted-by":"crossref","unstructured":"\u00c7\u00f6mez AT, Tufan HA, Kocabiyik \u00d6, Gencer B. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Curr Eye Res. 2013; 38: 1095\u20131103.","DOI":"10.3109\/02713683.2013.806670"},{"key":"i2164-2591-8-6-2-b31","doi-asserted-by":"crossref","unstructured":"Bonengel S, Bernkop-Schn\u00fcrch A. Thiomers\u2014from bench to market. J Control Release. 2014; 195: 120\u2013129.","DOI":"10.1016\/j.jconrel.2014.06.047"},{"key":"i2164-2591-8-6-2-b32","unstructured":"Williams DL, Mann BK. A crosslinked HA-based hydrogel ameliorates dry eye symptoms in dogs. Int J Biomater. 2013; 2013: 460437."},{"key":"i2164-2591-8-6-2-b33","doi-asserted-by":"crossref","unstructured":"Higashide T, Sugiyama K. Clin O. Use of viscoelastic substance in ophthalmic surgery\u2014focus on sodium hyaluronate. Clin Ophthalmol. 2008; 2: 21\u201330.","DOI":"10.2147\/OPTH.S1439"},{"key":"i2164-2591-8-6-2-b34","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Okamoto A, Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology. 1994; 31: 235\u2013244.","DOI":"10.3233\/BIR-1994-31302"},{"key":"i2164-2591-8-6-2-b35","doi-asserted-by":"crossref","unstructured":"Simmons PA, Vehige JG. Investigating the potential benefits of a new artificial tear formulation combining two polymers. Clin Ophthlamol. 2017; 11: 1637\u20131642.","DOI":"10.2147\/OPTH.S135550"},{"key":"i2164-2591-8-6-2-b36","unstructured":"Barnes HA, Hutton JF, Walters K, eds. An Introduction to Rheology. Vol. 3. Amsterdam, The Netherlands: Elsevier Science Publishers B.V.; 1989."},{"key":"i2164-2591-8-6-2-b37","doi-asserted-by":"crossref","unstructured":"Tiffany JM. Tears in health and disease. Eye. 2003; 17: 923\u2013926.","DOI":"10.1038\/sj.eye.6700566"},{"key":"i2164-2591-8-6-2-b38","doi-asserted-by":"crossref","unstructured":"Tiffany JM. The viscosity of human tears. Int Ophthalmol. 1991; 15: 371\u2013376.","DOI":"10.1007\/BF00137947"},{"key":"i2164-2591-8-6-2-b39","doi-asserted-by":"crossref","unstructured":"Gilbard JP. Human tear film electrolyte concentrations in health and dry-eye disease. Int Ophthalmol Clin. 1994; 34: 27\u201336.","DOI":"10.1097\/00004397-199403410-00005"},{"key":"i2164-2591-8-6-2-b40","doi-asserted-by":"crossref","unstructured":"Craig JP, Simmons PA, Patel S, Tomlinson A. Refractive index and osmolality of human tears. Optom Vis Sci. 1995; 72: 718\u2013724.","DOI":"10.1097\/00006324-199510000-00004"},{"key":"i2164-2591-8-6-2-b41","doi-asserted-by":"crossref","unstructured":"Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013; 11: 246\u2013258.","DOI":"10.1016\/j.jtos.2013.07.003"},{"key":"i2164-2591-8-6-2-b42","unstructured":"Thea Pharmaceuticals. Understanding dry eye and how to manage it. 2015. Available at: https:\/\/www.dropbox.com\/s\/8w67z6fi641afbu\/Thea_Dry_Eye_Consumer_Leaflet.pdf. Accessed April 10, 2019."},{"key":"i2164-2591-8-6-2-b43","doi-asserted-by":"crossref","unstructured":"Gilbard JP, Rossi SR, Heyda KG. Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation. Am J Ophthalmol. 1989; 107: 348\u2013355.","DOI":"10.1016\/0002-9394(89)90657-0"},{"key":"i2164-2591-8-6-2-b44","doi-asserted-by":"crossref","unstructured":"Aragona P, Di Stefano G, Ferreri F, Spinella R, Stilo A. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sj\u00f6gren's syndrome patients. Br J Ophthalmol. 2002; 86: 879\u2013884.","DOI":"10.1136\/bjo.86.8.879"},{"key":"i2164-2591-8-6-2-b45","doi-asserted-by":"crossref","unstructured":"Chen W, Zhang X, Li J, et al. Efficacy of osmoprotectants on prevention and treatment of murine dry eye. Invest Ophthalmol Vis Sci. 2013; 54: 6287\u20136297.","DOI":"10.1167\/iovs.13-12081"},{"key":"i2164-2591-8-6-2-b46","doi-asserted-by":"crossref","unstructured":"Corrales RM, Luo L, Chang EY, Pflugfelder SC. Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells. Cornea. 2008; 27: 574\u2013579.","DOI":"10.1097\/ICO.0b013e318165b19e"},{"key":"i2164-2591-8-6-2-b47","doi-asserted-by":"crossref","unstructured":"Hua X, Su Z, Deng R, Lin J, Li DQ, Pflugfelder SC. Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res. 2015; 40: 657\u2013667.","DOI":"10.3109\/02713683.2014.957776"},{"key":"i2164-2591-8-6-2-b48","doi-asserted-by":"crossref","unstructured":"Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface dysfunctions. Br J Ophthalmol. 2013; 97: 955\u2013960.","DOI":"10.1136\/bjophthalmol-2012-302568"},{"key":"i2164-2591-8-6-2-b49","unstructured":"SIFI S.p.A. Hyalistil BIO\u2014soluzione oftalmica umettante e lubrificante senza conservanti a base di sodio ialuronato 0,2%. 2018. Available at: https:\/\/www.sifigroup.com\/public\/HYALISTIL%20BIO1.pdf. Accessed April 19, 2019."},{"key":"i2164-2591-8-6-2-b50","unstructured":"TRB Chemedica UK. Vismed Multi. 2016. Available at: https:\/\/vismed.trbchemedica.co.uk\/products\/vismed-multi. Accessed April 10, 2019."},{"key":"i2164-2591-8-6-2-b51","unstructured":"RheoSense. Viscosity of Newtonian and non-Newtonian fluids. 2019. Available at: http:\/\/www.rheosense.com\/applications\/viscosity\/newtonian-non-newtonian. Accessed September 26, 2019."},{"key":"i2164-2591-8-6-2-b52","doi-asserted-by":"crossref","unstructured":"Simmons PA, Liu H, Carlisle-Wilcox C, Vehige JG. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial. Clin Ophthalmol. 2015; 9: 665\u2013675.","DOI":"10.2147\/OPTH.S78184"},{"key":"i2164-2591-8-6-2-b53","doi-asserted-by":"crossref","unstructured":"Abelson MB, Udell IJ, Weston JH. Normal human tear pH by direct measurement. Arch Ophthalmol. 1981; 99: 301.","DOI":"10.1001\/archopht.1981.03930010303017"},{"key":"i2164-2591-8-6-2-b54","doi-asserted-by":"crossref","unstructured":"Paugh JR, Chatelier RC, Huff JW. Ocular residence time of carboxymethylcellulose solutions. In: DA, Sullivan Dartt DA, Meneray MA, eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Boston, MA: Springer; 1998: 761\u2013767.","DOI":"10.1007\/978-1-4615-5359-5_107"},{"key":"i2164-2591-8-6-2-b55","doi-asserted-by":"crossref","unstructured":"Cowman MK, Schmidt TA, Raghavan P, Stecco A. Viscoelastic properties of hyaluronan in physiological conditions. F1000Res. 2015; 4: 622.","DOI":"10.12688\/f1000research.6885.1"},{"key":"i2164-2591-8-6-2-b56","doi-asserted-by":"crossref","unstructured":"Rogo\u0161ic M, Mencer HJ, Gomzi Z. Polydispersity index and molecular weight distributions of polymers. Eur Polym J. 1996; 32: 1337\u20131344.","DOI":"10.1016\/S0014-3057(96)00091-2"},{"key":"i2164-2591-8-6-2-b57","doi-asserted-by":"crossref","unstructured":"Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II introduction. Ocul Surf. 2017; 15: 269\u2013275.","DOI":"10.1016\/j.jtos.2017.05.005"},{"key":"i2164-2591-8-6-2-b58","unstructured":"Litwiniuk M, Krejner A, Grzela T. Hyaluronic acid in inflammation and tissue regeneration. Wounds. 2016; 28: 78\u201388."},{"key":"i2164-2591-8-6-2-b59","unstructured":"Petrey AC, de la Motte CA. Hyaluronan, a crucial regulator of inflammation. Front Immunol. 2014; 5: 101."},{"key":"i2164-2591-8-6-2-b60","doi-asserted-by":"crossref","unstructured":"Ruppert SM, Hawn TR, Arrigoni A, Wight TN, Bollyky PL. Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res. 2014; 58: 186\u2013192.","DOI":"10.1007\/s12026-014-8495-2"},{"key":"i2164-2591-8-6-2-b61","doi-asserted-by":"crossref","unstructured":"Mencucci R, Boccalini C, Caputo R, Favuzza E. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. J Cataract Refract Surg. 2015; 41: 1699\u20131704.","DOI":"10.1016\/j.jcrs.2014.12.056"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2754757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T03:35:43Z","timestamp":1721964943000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2754757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.8.6.2","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}